Applied Statistics

Hepatology: Pfizer

Total Score People Score Events Score
15 14 11
Date Event Presentation Speakers
June 27, 2011 RNAi, miRNA & siRNA Second Chair’s Closing Remarks and Close of Day Two Sterghios Moschos
PANNEL DISCUSSION | Epigenetics in RNAi Sterghios Moschos
First Chair's Opening Remarks Sterghios Moschos
November 6, 2009 Clinical Applications for Age Management Medicine Continental Breakfast Erik Kuja
August 3, 2009 The Next Wave of Antibody Therapeutics Clinical Development of the IGF-IR inhibitor Figitumumab for the Treatment of Cancer Antonio Gualberto
June 16, 2009 4th Annual Cell Based Assays Tackling the challenges of ion channels: developing assays to bridge the gap between experiments and patients Dermot O' Callaghan
Opening remarks from the Chairperson Darren Cawkill
Big isn't always beautiful: effective hit identification using subset screening for ion channels Helen Boyd
Closing remarks from the Chairperson Darren Cawkill
June 8, 2009 RNAi for Functional Screens OPTIMIZING RNAi DELIVERY FOR IN VITRO APPLICATIONS Stanley M Speaker
March 25, 2008 Mastering Medicinal Chemistry Discovery and Development of Potent and Highly Selective c-Met/ HGFR Inhibitors Robert Kania
November 7, 2007 Srial II: Advances and Challenges Toward Major Diseases: Extension on New Hope Nov (07-13) Session 16: Protein and Peptide Drug Development (13:30-17:00) Anton Fliri, Xing Wang
Session 16: Studies on the Origin of Protein Network Topologies (14:50-15:10) Anton Fliri
Session 16: Analytical Challenges in Protein Therapeutics Development (13:30-13:50) Xing Wang
October 17, 2007 Exploring Next Generation Sequencing: Applications and Case Studies (Oct 17-18) Deep Sequencing: Deep Sequence Analysis of Clinically Relevant env Region Sequence Variants from HIV (13:35-14:05) Marilyn Lewis
Deep Sequencing (12:00-15:30) Marilyn Lewis
October 16, 2007 Inaugural HDAC inhibitors: Meeting the Challenges of Chemical Development of HDAC Inhibitors Oct (16 -17) Keynote Session: Executive Panel: Delivering Drugs for Difficult Targets(08:40-09:40) Alexander Rod MacKenzie
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Third Annual Toxicity Biomarkers; TOXICITY BIOMARKER DISCOVERY (08:30-11:00) Frances Clemo
Third Annual Toxicity Biomarkers; TOXICITY BIOMARKER DISCOVERY: Preclinical Biomarkers of Hepatotoxicity: What’s new? (09:35-10:05) Frances Clemo
Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Jean W Lee
July 7, 2007 Protein Kinases and Protein Phosphorylation Distinct and Overlapping actions of KSR1 and KSR2 In Vivo and In Vitro Marilyn Lewis
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.